节点文献

不同结合臂长10-23DNAzymes对乙型肝炎病毒S基因和C基因表达的抑制作用

Inhibition of hepatitis B virus S gene and C gene expression by different 10-23 DNAzymes substrate-recognition domains

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 侯伟沃健儿刘克洲李敏伟陈离伟胡中荣刘荣华胡敏君

【Author】 HOU Wei, WO Jian-er, LIU Ke-zhou, LI Min-wei, CHEN Li-wei, HU Zhong-rong, LIU Rong-hua, HU Min-jun. Institute of Infectious Diseases, the First Affiliated Hospital, College of Medical Sciences, Zhejiang University; Key Laboratory of Infectious Diseases, Ministry of Public Health, Hangzhou 310003, China

【机构】 浙江大学医学院附属第一医院传染病研究所卫生部传染病重点实验室浙江大学医学院附属第一医院传染病研究所卫生部传染病重点实验室

【摘要】 目的探讨不同结合臂长1023DNAzymes在2.2.15细胞内对乙型肝炎病毒S基因和C基因表达的抑制作用。方法设计并合成不同结合臂长的1023DNAzymes,能分别针对乙型肝炎病毒S基因和C基因开放阅读框A157UG和A1816UG。不同的1023DNAzymes分别转染2.2.15细胞,放射免疫分析法测定2.2.15细胞培养上清中HBsAg和HBeAg水平,实时荧光定量PCR法测定2.2.15细胞培养上清中HBVDNA水平。MTT法检测细胞毒性。结果不同结合臂长的1023DNAzymes在0.1~2.5μmol/L浓度范围内均能有效抑制HBsAg和HBeAg的表达,抑制效应可长达72h。在同一剂量相同转染时间的条件下,不同结合臂长的1023DNAzymes对HBsAg和HBeAg表达的抑制率呈以下关系:DrzBS9>DrzBS8>DrzBS7;DrzBC9>DrzBC8>DrzBC7。DrzBS9和DrzBC9在2.5μmol/L剂量条件下,转染48h后对HBsAg和HBeAg表达的抑制率可分别高达95%和92%。不同结合臂长的1023DNAzymes对2.2.15细胞培养上清中HBVDNA水平并无明显影响。MTT细胞毒性检测表明,在0.1~2.5μmol/L浓度范围内未见1023DNAzymes对2.2.15细胞的毒性作用。结论不同结合臂长1023DNAzymes在2.2.15细胞内对乙型肝炎病毒S基因和C基因表达均有一定的抑制作用,DrzBS9和DrzBC9的抑制作用较强。

【Abstract】 Objective To explore the inhibition effects of 10-23 DNAzymes with different substrate-recognition domains targeting hepatitis B virus (HBV) S gene and C gene expression in 2.2.15 cells. Methods 10-23 DNAzymes with different substrate-recognition domains specific to HBV S gene open reading frame (ORF) A 157UG and HBV C gene ORF A 1816UG were designed and synthesized, respectively. Different 10-23 DNAzymes were transfected into 2.2.15 cells which is a stable HBV producing cell line. HBsAg and HBeAg secreted into culture media were detected by radioimmunoassay (RIA) and HBV DNA levels were measured by real-time PCR. 3-(4,5-dimethylthiagol-2-yl)-2,5-drphnyl tetragolium brornide (MTT) assays were performed to evaluate cytotoxicity. Results HBsAg and HBeAg expressions were reduced by various DNAzymes (0.1-2.5 μmol/L) with different substrate-recognition domains after transfection. The antiviral effects of DNAzymes were apparent until 72 h post-transfection. The inhibition rates of the DNAzymes at the same dose on HBsAg and HBeAg in the same period of post-transfection were as the following: DrzBS-9>DrzBS-8>DrzBS-7; DrzBC-9>DrzBC-8>DrzBC-7. Among all the DNAzymes used, DrzBS-9 targeting S gene and DrzBC-9 targeting C gene were most potent, with HBsAg and HBeAg reduced 95% and 92% 48 h post-transfection at the dose of 2.5 μmol/L, respectively. The inhibition effects on HBV DNA by various DNAzymes with different substrate-recognition domains were of no significance. There were no evident cytotoxic effects of these DNAzymes in the range from 0.1 to 2.5 μmol/L. Conclusion 10-23 DNAzymes with different substrate-recognition domains targeting HBV S gene and C gene mRNA possessed specific inhibition effects in 2.2.15 cells, and DrzBS-9 targeting S gene and DrzBC-9 targeting C gene were most potent.

【关键词】 肝炎病毒,乙型10-23 DNAzymeS基因C基因
【Key words】 Hepatitis B virus10-23 DNAzymeS geneC gene
【基金】 国家自然科学基金资助项目(30271183;30471539)
  • 【文献出处】 中华内科杂志 ,Chinese Journal of Internal Medicine , 编辑部邮箱 ,2006年05期
  • 【分类号】R373.21
  • 【被引频次】4
  • 【下载频次】65
节点文献中: 

本文链接的文献网络图示:

本文的引文网络